Antipsychiatrics & Antidepressants
Research DescriptionDr. Burgoyne's primary clinical research focus involves second generation antipsychotics, many novel antidepressants, and some anxiolytics. Multicentered projects include CATIE and STAR-D. His more recent research efforts have focused on the prediction of antidepressant responses using quantitative EEG measurements.
- BS, University of Southern California
- MD, University of Southern California School of Medicine